Welcome to LookChem.com Sign In|Join Free
  • or
3-(phenylamino)phenylboronic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1201643-68-6

Post Buying Request

1201643-68-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1201643-68-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1201643-68-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,6,4 and 3 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1201643-68:
(9*1)+(8*2)+(7*0)+(6*1)+(5*6)+(4*4)+(3*3)+(2*6)+(1*8)=106
106 % 10 = 6
So 1201643-68-6 is a valid CAS Registry Number.

1201643-68-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (3-anilinophenyl)boronic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1201643-68-6 SDS

1201643-68-6Downstream Products

1201643-68-6Relevant academic research and scientific papers

PHOSPHATIDYLINOSITOL 3 KINASE INHIBITORS

-

Page/Page column 133, (2010/01/12)

Provided are compounds according to Formula (I), or stereoisomer, prodrug, polymorph, or pharmaceutically acceptable salt forms thereof, wherein X, Y, R1, R6 , R7, and R8 are as defined, which compounds are effective inhibitors of PI3-kinase and/or other medically and clinically relevant kinases. Also provided are pharmaceutical compositions and methods of using the compounds and compositions as PB -kinase and kinase inhibitors. More particularly, the compounds of the invention provide treatments and therapeutics for human diseases regulated by, or associated with, the activity of, PI3-kinases and/or protein kinases, or mutant or variant forms thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1201643-68-6